Tess O'Meara

8PUBLICATIONS
76CO-AUTHORS
Molecular targetsInnate immunityCancer therapy (excl. chemotherapy and radiation therapy)Structural properties of condensed matterPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Mar 23, 2026
The Pan-Tumor Landscape of Gene Amplifications and Copy Number Amplification Ratio for Established and Emerging Clinical Targets.

Jessica K Lee, Julia C F Quintanilha, Kuei-Ting Chen

|Feb 06, 2026
Different Diseases, Different Escapes: Trastuzumab Deruxtecan Resistance in HER2-Amplified versus HER2-Low Breast Cancer.

Tess A O'Meara, Paolo Tarantino

|Sep 04, 2025
Immunoprofiling at an Institutional Scale Reveals That High Numbers of Intratumoral CD8<sup>+</sup> and PD-1<sup>+</sup> Cells Predict Superior Patient Survival Across Major Cancer Types Independent of Major Risk Factors.

Joao V Alessi, James R Lindsay, Anita Giobbie-Hurder

|Jan 22, 2025
Lessons From Taxanes Versus Eribulin for First-Line Metastatic Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer in the EMERALD Study.

Tess A O'Meara, Paolo Tarantino

|Jul 07, 2022
Multidimensional Molecular Profiling of Metastatic Triple-Negative Breast Cancer and Immune Checkpoint Inhibitor Benefit.

Romualdo Barroso-Sousa, Juliet Forman, Katharine Collier

|Mar 05, 2022
Comprehensive Analysis of Metabolic Isozyme Targets in Cancer.

Michal Marczyk, Vignesh Gunasekharan, David Casadevall

Pageof 2

Frequent Collaborators

3 joint publications

Sara M Tolaney

3 joint publications

Lajos Pusztai

2 joint publications

Nancy U Lin

2 joint publications

Eliezer M Van Allen